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ABSTRACT Considering the increasing incidence of infectious bovine rhinotracheitis (IBR) in Indonesia, it was necessary to
conduct a more in-depth study of bovine herpesvirus-1 (BHV-1) as the causative agent of IBR disease. Previous research
reports indicate that the BHV-1 subtypes found in Indonesia are subtype 1.1. Currently, IBR field case detection in Indonesia
still uses the serological method (ELISA), which has the potential to give false positive results and cannot explain the virus
subtype. Other detection methods, such as viral isolation, take longer and require adequate resources. This study aimed to
determine the BHV-1 subtypes of Indonesian isolates using molecular techniques. Nested PCR using two pairs of primers
was successfully used to amplify the glycoprotein D (gD) gene. The gD gene fragment was cloned into the pGEM-T plasmid.
Analysis of the gD gene sequence was subsequently carried out to determine the BHV-1 character of the Indonesian isolates.
The results indicated that the isolates were different from the previous isolates, and had similarities (100%) with subtype 1.2
strain SP1777 and SM023.
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1. Introduction
Infectious bovine rhinotracheitis (IBR) disease was one of
the major animal diseases in Indonesia because it inflicted
considerable economic losses in the livestock sector. This
disease caused a decrease in livestock performance, as was
indicated by weight loss, low milk productivity, abortion,
and the occurrence of specific symptoms including abor-
tus, vulvovaginitis in heifers and balanoposthitis in bulls,
and encephalitis (Turin et al. 1999). The causal agent of
the disease was bovine herpesvirus-1 (BHV-1) (Turin et al.
1999), which is classified in the Alphaherpesvirus subfam-
ily and the genus of Varicellovirus. BHV-1 causes latency
conditions for the host. Following primary infection, the
virus will be transported to a neuronal body cell and es-
tablish lifelong latency. When an animal is under stress
or exposed to corticosteroidal drugs (Zhu et al. 2017), the
virus can be reactivated. The cattle can show either some
clinical or subclinical symptoms (Rola et al. 2005). Both
can transmit viruses through secretions from genital infec-
tions, artificial insemination, nasal discharge, as well as
embryos.
The BHV-1 genome consists of double-stranded DNA
of the length of 138 kbp (Vlček et al. 1995). The genome
of the virus can evolve by three systems: mutation dur-
ing replication, acquisition, and recombination with other
genes (Schynts et al. 2003b). The BHV-1 genome is
grouped inD-class herpesvirus together with pseudorabies
(PRV), VZV, and EHV-1 (Muylkens et al. 2007). A varia-
tion in the genome of BHV-1 that consists of mutation and
recombination would be possible to emerge. The rate of
synonymous nucleotide substitution per site per year was
estimated to be 2 to 30 times of the host genome (Schynts
et al. 2003b). The glycoprotein D (gD) gene is underlying
in the US segment, which is flanked at both ends by an
inverted repeat and target for vaccine development (Dum-
mer et al. 2014). The vaccine using gD subunit is most
efficacious at reducing clinical disease and virus excre-
tion (Muylkens et al. 2007). Furthermore, there are vac-
cine markers by omitting some genes that encode the gly-
coprotein, such as gC, gE, gI, and gG (van Engelenburg
et al. 1994; Kaashoek and Van Oirschot 1996; Strube et al.
1996), and the genes that encode nucleic acid metabolism
(Kit et al. 1985; Smith et al. 1994). Some vaccine pro-
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TABLE 1 Some advantages and disadvantages of several types of IBR vaccine around the world.
Vaccine
type
Advantages Disadvantages Country Reference
Killed
vaccine
Induces immune response;
relatively safe for hospes;
more stable; easy to produce;
relatively insignificant side
effects
High production cost; more than one application;
requires adjuvant that it may result in
hypersensitivity and urticaria; there is still
possibility for latency; there is not any
“companion test”; susceptible to storage
problems; causes bias in incomplete inactivation
USA;
Australia
Ackermann and
Engels (2006);
Babiuk (2002); van
Donkersgoed et al.
(1995)
Modified
live vaccine
Induces fast immune response;
action is similar to natural
infection; long immunity
duration
Does not prevent latency; causes virus shedding
and abortus; there is not any “companion test”;
can cause virus recombination; requires a big
quantity of antigen; can react to other proteins or
adjuvants; its immunity period is short; does not
give any local immunity
Northern
Ireland;
USA
Ackermann and
Engels (2006);
Cowley et al.
(2014); Babiuk
(2002)
Vaccine
subunit
Induces good immune
response
High purification cost; requires adjuvant European
Union
Babiuk (2002)
Vaccine
marker
Is temperature resistant; does
not cause any virus shedding;
induces good immunity
Requires companion test in testing European
Union
Raaperi et al.
(2015); Babiuk
(2002)
Multivalent
vaccine
Cannot control
immunomodulation and causes
side effects
Gives immunity against some disease agents in a
safer way; is practical and efficient; gives
immunity
- Babiuk (2002)
Vaccine
DNA
Very safe; the endogenously
produced antigen induces good
immune response in children
with passive antibodies
Highcost; selectiveapplicationrulesbecauseof its
relationship with genetic material
- Babiuk (2002)
ducers in the world create IBR vaccines. Table 1 summa-
rizes some advantages and disadvantages of the existing
IBR vaccines. The IBR vaccines that are commercially
available include killed/inactive vaccines, the modified
live virus (MLV), subunit vaccine, marker vaccine, multi-
valent vaccine, and DNA vaccine. TheMLV is not applied
for any longer because of its disadvantages, including
virus latency in cattle that enables virus re-activation and
virus shedding. Though there are some vaccines produced
on the basis of their application, such as an intranasal ap-
plication that prevents abortus in pregnant cattle, the vac-
cine is also not applied for any longer because its manage-
ment cost is very high as a result of the screening of the
pregnant cattle that should be conducted in advance. The
killed vaccine is considered safer than the ML vaccine be-
cause it does not result in latency and reduces virus shed-
ding. However, the production cost of the killed vaccine is
high, while it should be applied repeatedly and requires ad-
juvant that may cause hypersensitivity and urticaria. The
possibly incomplete inactivation process can cause a new
infection. Cattle vaccinated with the killed vaccine may
be re-infected by the virulent virus after a certain period
of time and it causes virus shedding and spreads the infec-
tion in the cattle group (Kit et al. 1985). The application
of the subunit vaccine can prevent the transmission of the
disease to other animals because antigenically the subunit
vaccine does not contain any live virus. It also does not
cause any latency and any abortus in animals. The subunit
vaccine can prevent infection symptoms and virus shed-
ding. The disadvantages of the vaccine are that it cannot
induce a good immune response in young animals, its pu-
rification cost is high, and it requires some adjuvants (Kit
et al. 1985).
Based on molecular studies, BHV-1 consists of sub-
type 1.1; subtype 1.2a and subtype 1.2b (Metzler et al.
1985). Several years ago, BHV-1 subtypes included BHV-
1.3, a cause of encephalitis in calves (Collins et al. 1993).
More recently, BHV-1.3 was classified as BHV-5. A fur-
ther study divided BHV-5 into subtype 5a, 5b, “non-a non-
b” and c (Pidone et al. 1999). Subtype 1.1 is found pre-
dominantly in Europe and the USA (Spilki et al. 2004).
Subtype 1.2 consists of two further subtypes, 1.2a and
1.2b. Subtype 1.2a is prevalent in Brazil and was present
in Europe before 1970. Subtype 1.2b was reported in Aus-
tralia and Europe, but not in Brazil (Jones and Chowd-
hury 2007). A study by Saepulloh et al. (2009) showed
that isolates obtained from Java, Indonesia, turned to sub-
type 1.1. Until now, Indonesia has based the technology
of making vaccines on whole viruses. Vaccine technology
based on genetic engineering such as sub-unit vaccines,
vaccine markers, or markers by removing several parts of
the viral genes (especially for IBR disease) has not been
investigated, as it requires large resources and supporting
policies. Indonesia is still preparing itself for the appli-
cation of this technology. At present, the government is
planning to make IBR inactive vaccines from local iso-
lates. Research on making inactive vaccines has been con-
ducted by the Veterinary Disease Research Center (Balai
Besar Penelitian Veteriner, Balitvet), but the local vaccine
has not given any optimal protection (Sudarisman 2006).
The symptoms caused by subtype 1.1 and subtype
1.2 can show infection in both the respiratory and genital
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tracts of the animal, which is different from the previous
hypothesis that stated respiratory symptoms are caused
more by subtype 1.1 and genital symptoms caused by sub-
type 1.2 (Muylkens et al. 2007). The difference between
virus subtype 1.2a and subtype 1.2b is the presence or ab-
sence of abortion in cattle. One study of BHV-1 isolated
from several cases in Java indicated that the subtype devel-
oped in Indonesia was subtype 1.1 (Saepulloh and Adjid
2010). By considering the increasingly widespread inci-
dence of the disease, it was necessary to conduct a study
on the molecular characteristics of the viruses, especially
those coming from outside Java. It was also essential to
find out the possibility of other subtypes in Indonesia as
the basis for the investigation of exotic diseases in Indone-
sia. The difference in the subtype is useful both as study
material and for the clustering of the virus’s origin. At the
same time, the detection of the condition using serological
methods is inadequate in terms of establishing the charac-
teristics of an isolate.
Currently, for monitoring purposes, the investigation
center still uses serological methods for disease detection.
The serological screening included ELISA and serum neu-
tralization (SN) tests (Parreño et al. 2010). However, these
tests have advantages and disadvantages. ELISA requires
considerable time and resources. To obtain more valid re-
sults, two rounds of ELISA testing are required (especially
for positive initial results), by comparing the titer within
21 days. An increase in antibody titers indicates an acute
infection or reactivation. If serum antibodies decrease, it
can be considered that the disease is latent (Turin et al.
1999). A serum neutralization test also requires a long test-
ing time and vast resources (Bashir et al. 2011). The SN
test processes include cell culture and antibody testing in
susceptible cells. However, between these two serological
methods, ELISA provides the higher sensitivity. ELISA
may result not only from neutralization antibodies such
as immunoglobulin but also other non-neutralization anti-
bodies (Payment et al. 1979). Otherwise, the SN test does
not depend on the type and the subtype of the viruses that
develop in the field (Varela et al. 2010).
The detection of diseases using serological methods
is not enough in establishing the characteristics of an iso-
late. PCR tests are now preferable to serological tests be-
cause they have higher sensitivity and specificity. This
study aimed to provide better information of the charac-
teristics of BHV-1 isolated from a recent field case and to
describe the development of the detection methods using
PCR cloning and sequencing of the BHV-1 isolate to de-
fine the subtype.
2. Materials andmethods
This research was permitted by the Committee for Safe
Handling of Living Modified Organism in Ehime Univer-
sity (permission number: H28-05) and accomplished ac-
cording to the guidelines of the committee. The samples
of the study were drawn from the tracheal section in field
cases from Lampung, Indonesia, as previously reported
(Hidayati et al. 2018). The samples were collected from
Veterinary Disease Investigation Lampung (Balai Veter-
iner Lampung), based on the permission letter of mate-
rial transfer number 05010/PD.650/F5.H/06/2015. The
preparation of the sample organ was maintained in HBSS
solution (Gibco, Life Technologies, Grand Island, USA).
The organ was sterilized by washing it three times using
phosphate buffer saline (PBS) solution. The initial wash
used a PBS mixture with antibiotics (1000 IU/mL Peni-
cillin, 1000 µg/mL Penicillin-Streptomycin sulfate) and
Kanamycin (Meiji, PT Meiji Indonesian Pharmaceutical
Industries, Bangil, Indonesia). In a glass mortar, samples
were crushed using a mixture of sterilized quartz sand and
DMEM (Gibco, Life Technologies, Grand Island, USA).
The solution containing the crushed organ was centrifuged
at 1000 rpm for 5 min, and the supernatant was filtered us-
ing a Sartorius filter 0.2 µm. The aqueous filtering prepa-
ration was used in DNA extraction and viral-isolation.
2.1. Virus isolation
Primary Madin Darby Bovine Kidney (MDBK) mono-
layer cell free of bovine viral disease (obtained from
PUSVETMA, Indonesia) was grown in Dulbecco’s Mod-
ified Eagle medium (DMEM, Gibco, Life Technologies,
Grand Island, USA) supplemented with 2 mM l-glutamine
(Gibco, Life Technologies, Grand Island, USA), 10% fe-
tal bovine serum (FBS, Sigma–Aldrich, St. Louis, USA),
1000 µg/mL streptomycin, 1000 IU/mL penicillin, and
250 µg/mL kanamycin (PT. Meiji Indonesian Pharmaceu-
tical Industries, Bangil, Indonesia). Two flasks of the cell
line were used. One milliliter of virus suspension was in-
oculated into the first flask, while the other was used as the
control. The flask containing the suspension of the virus
was incubated for an hour at 37°C to allow the virus to ad-
sorb the monolayer cell. Then media containing 2% FBS
was added into the flask. After one hour of incubation, the
culture was stored at 37°C for 3–5 days and followed by
daily observation for a cytopathogenic effect (CPE).
2.2. DNA extraction
The DNA extraction was prepared based on the manufac-
turer’s protocol (Qiagen, cat. no. 61304, Hilden, Ger-
many). The final nucleic acid was eluted in 0.2 mL elution
buffer consisting of 0.5 mM EDTA and 10 mM Tris-Cl at
pH 9.0. The concentration of the DNA in the DNA extrac-
tion was measured using a BioSpec-nano spectrophotome-
ter at 260/280 nm (Shimadzu Biotech, Japan).
TABLE 2 The primer used in the study.
Primer
name
Sequence PCR
product
length
gD-F1 GCTGTGGGAAGCGGTACG 468 bp
gD-R1 GTCGACTATGGCCTTGTGTGC
gD-F2 ACGGTCATATGGTACAAGATCGAGAGCG 325 bp
gD-R2 CCAAAGGTGTACCCGCGAGCC
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2.3. Nested PCR
PCR was carried out using two pairs of primer and two-
phase PCR. The primer sequences are shown in Table 2
(Wiedmann et al. 1993). Each step consisted of 2.5 mM
MgCl2, 0.3 mM for each dNTPs, 1 U of DNA polymerase,
10 pmol forward and reverse primer, template DNA of less
than 100 ng per reaction, and PCR grade water up to 50
µL. The PCR cocktail was formulated in accordance with
the KAPA HiFi HotStart ReadyMix (KAPA Biosystems,
Wilmington, USA) guidance. The first phase was carried
out with an initial denaturation at 95°C for 3 min, denat-
uration at 98°C for 20 s, annealing at 53°C for 15 s in 35
cycles, extension at 72°C for 15 s, and the final extension
at 72°C for 5 min. The second phase was similar, except
for the annealing temperature, which was at 59.5°C for
15 s. The PCR assay followed using a Takara Thermal
Cycler Dice Gradient TP600 (Takara, Shiga, Japan). The
PCR product was evaluated using gel agarose at a concen-
tration of 1.5%. The electrophoresis ran on 100 A. The
agarose was soaked in ethidium bromide for about 15 min
before UV transillumination visualization.
2.4. PCR cloning and sequencing
The second round PCR product was added with 10x A-
attachment (Toyobo, Osaka, Japan) and was purified us-
ing the Fast gene gel/PCR extraction kit (Nippon Genet-
ics, Tokyo, Japan). The DNA fragment was then ligated
into plasmid pGEM-T (Promega, Madison, USA) by T4-
ligase enzyme (Promega, Madison, USA). The plasmid
was transformed into competent E. coli C3040 (NEB®
stable, High efficiency, New England BioLabs, Ipswich,
USA) and incubated overnight at 37°C. After incubation,
the white and smooth colony was picked up with a ster-
ilized toothpick and transferred into LB broth media con-
taining 100 µL ampicillin per mL and incubated at 37°C
overnight with constant shaking. After preparation by
chemistry lysis (Sambrook et al. 1989), the plasmid was
confirmed using PCR amplification with the designated
primers. The cloned plasmid was purified using the Fast
Gene plasmid mini kit (Nippon Genetics, Tokyo, Japan)
and the purity level was measured using a BioSpec-nano
spectrophotometer (Shimadzu, Kyoto, Japan). The high
concentration plasmid was digested using ScaI (Takara
Bio, cat. no. 1084A, USA,) for 60 min at 37°C, and
20 min at 80°C. DNA sequencing was carried out us-
ing a Applied Biosystems 3130 Genetic Analyzer (Ap-
plied Biosystems, Foster City, USA) and BigDye Ter-
minator V3.1 cycle sequencing kit at the annealing tem-
perature of 50°C with the M13 primer method. The
BLAST software was used to confirm the similarity of
the sample with the alphaherpesvirus. The sequence data
were analyzed using Seq Man from the DNASTAR Laser-
gene software (version 7). The alignment was made us-
ing reference genes retrieved from a gene bank with ac-
cession numbers AJ004801.1, KU198480.1, JX898220.1,
KY215944, KM258882.1, and KM258883.1. The nu-
cleotide sequence was deposited in the DNA Data Bank
of Japan (DDBJ) with accession number LC425527.
2.5. Sequence analysis and in silico restriction enzyme
analysis
Analysis of the in silico restriction enzyme was carried
out using TaqI and AluI provided by the SeqBuilder pro-
gram (DNASTAR Lasergene ver 7). TaqI will cut (5 ’)
TC-GA (3’) sequences, and TaqI will cut (5 ’) AG-CT (3’)
sequences. Sequence analysis and the construction of a
phylogenetic tree were performed using theMegAlign pro-
gram (DNASTAR Lasergene ver 7).
3. Results
3.1. Cytopathogenic effect (CPE) of virus culture
According to Nandi et al. (2009), the CPE of specific
BHV-1 is characterized by a grape-like cluster. The cy-
topathogenic effect was observed on day three after inoc-
ulation. The more vacuoles found and followed by cell
(a) (b)
FIGURE 1 (a) SampleW5 after three days of observation. The CPEwas observed as a grape-like cluster. Pointer indicates cleft aroundmono-
layer. (b) The control of the MDBK cell line after three days of observation. The pictures were taken using an inverted microscope (Nikon
Ecclipse, TE 2000-U, Japan) at the samemagnification (10x).
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rupture. The visualization of the CPE is shown in Figure
1a. The grape-like cluster of the globular cell engirdled
around the cleft in the monolayer, which resulted in a very
different visualization of control cells that were not inocu-
lated by the virus (Figure 1b).
3.2. PCR cloning and sequencing
The sample showed positive amplification of the glyco-
protein D gene, which was made using the nested PCR
method. Cloning and sequencing procedures followed, in
order to obtain readable sequencing results considering
that some bands were very thin (Hidayati et al. 2018). The
PCR product of the second phase of amplification was suc-
cessful, ligated in the pGEM-T. The white colony of the
plasmid was spread evenly on the LB plate, as show in Fig-
ure 2. Ten colonies were picked up from the plate to the
culture in the LB broth media to multiply the plasmids. Af-
ter incubation overnight and purification (Fast Gene, Nip-
pon Genetics, Japan), the plasmids were run in gel agarose
electrophoresis to confirm the positive result using the sec-
ond primer. The cloned plasmids (no. 9 and 10, Figure 3)
were about 325 bp (positive). This recombinant plasmid
FIGURE 2 The colony of the transformant after 18 hours of incuba-
tion.
FIGURE3Theconfirmationof the insertedgenebygel agaroseelec-
trophoresis. The length of the inserted gene is about 325 bp of
the targeted gene plus approximately 141 bp of pGEM-T multiple
cloning region, resulted of about 466 bp).
was purified using the Fast Gene (Nippon Genetics, Japan)
plasmid mini kit and was cut with the ScaI restriction en-
zyme to obtain a linear band. The sample sequence and
reference gene were aligned using MegAlign (DNASTAR
Lasergene ver. 7). The electropherogram result of the
cloned fragment is shown in Figure 4. The nucleotide phy-
logenetic tree was reconstructed using DNASTAR Laser-
gene, as shown in Figure 5. The Bootstrap 1000x was
found out using the neighbor-joining method. The branch
lengths were measured using the Kimura method.
3.3. Sequence analysis
The region of gD (nt 118129 – 118446 based onORF of ref.
no. KU198480.1) consisted of about 318 nt. TheG+C con-
tent was 64%. The alignment result showed SNPs that dis-
tinguished BHV-1.1 and BHV-1.2 at four sites (nt 118258,
118281, 118422, 118427 of ORF ref. no. KU198480.1)
(Table 3). Only a transition mutation occurred (A-G and T-
C). The resulting alignment of the sequence showed a high
similarity between BHV-1.1, BHV-1.2, and the sample. It
confirmed the mean ± SD identities of 98.70% ± 0 (BHV-
1.1 vs. sample) and 100% ± 0 (BHV-1.2 vs. sample). The
calculation of the synonymous and nonsynonymous ratio
(dn/ds) was 0.34 (dn/ds<1).
3.4. In silico restriction enzyme analysis
Restriction enzyme analysis using in silico AluI and TaqI
showed a number of different intersection points between
subtype 1.1 and subtype 1.2, as presented in Table 4. Sub-
type 1.1 showed two points of intersection with AluI (nt
126 and 163 of the gD sample), while TaqI showed four
intersection points (nt 21, 198, 228, and 290 of the gD
sample). Subtype 1.2 showed three points (nt 126, 163,
and 295 of the gD sample) of intersection using AluI and
five points using TaqI (nt 21, 198, 228, 290, and 297 of
the gD sample). The sample showed an intersection map
of the restriction enzyme that was the same as that of sub-
type 1.2.
4. Discussion
Viral isolation aims to determine the presence of a virus
in a specimen. It assumes viral positive if any particu-
lar CPE is shown in the monolayer of a susceptible cell.
In this study, the CPE was observed on day three, as in-
dicated by retractile and globular cells to corners and the
formation of a grape-like cluster (Nandi et al. 2009). Cells
TABLE 3Nucleotide polymorphism analysis.
Position along sequence
based onORF of ref. no.
KU198480.1
Nucleotide
comparison to
subtype 1.1
Polymorphism
118258 T→ C Transition
118281 G→ A Transition
118422 A→G Transition
118427 G→ A Transition
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FIGURE 4 Analysis of electropherogram which indicated the point of mutation (arrows). The fragment consists of about 325 bp. The yellow
background states the process of an initial sequence of dye terminator.
will experience rupture over time, which is consistent with
Weiblen et al. (1992). The presence of the globular cells
that subsequently burst is a sign of cell damage because
of virus replication. Other CPE occurred with the forma-
tion of more plaque. The nucleocapsids in the cytoplasm
are transported to the Golgi apparatus that small vacuoles
form, which contains enveloped virions and is transported
to the plasma membrane for the exocytosis process. The
development of apoptosis and necrosis give rise to the
death of the cell (Muylkens et al. 2007).
The fusion of the virus initiates apoptosis, which in-
duces the decrease of the CD4+ of T cells. Therefore,
BHV-1 infection disrupts the immune response and causes
a BRDC infection (Jones and Chowdhury 2007). The
MDBK control cells still seemed to be intact. The MDBK
cells were susceptible to BHV-1 infection. They can ex-
press glycoprotein D of the BHV-1 and resistant to the in-
terference of other heterologous viruses such as HHV-1
(human herpesvirus-1) and SuHV-1 (suid herpesvirus-1).
BHV-1 enters the cells through natural bonding between
the glycoprotein B and glycoprotein C with the heparin
sulfate receptor followed by the bond between the glyco-
protein D and specific cellular receptor and causes virus fu-
sion with the plasmamembrane. Through this mechanism,
the virus penetrates the susceptible cells. Glycoprotein D
plays an essential role as a receptor-mediated agent for the
viral antigen to enter the cells. GlycoproteinD is also a cru-
cial gene in cell-to-cell spread. BHV-1 can intracellularly
enable cell-to-cell spread, causing an inability of the anti-
body to prevent the spread of the virus (Babiuk et al. 1996).
The CPE of the sample was found at the first passage on
theMDBK cell line. For detection purposes, the specimen
FIGURE 5 The result of the phylogenetic tree of the sample (W5)
and the reference genes. SampleW5 is grouped in BHV-1.2.
was considered to be negative after three times passages.
In the cells infected by a herpes virus, virus replication
takes place in the cell nucleus. The intranuclear formation
can be observed, which enlarges the presence of an inclu-
sion body of Cowdry type A (inclusion body, observable
with eosinophil staining). The nucleus produces nucleo-
capsids for virion and will be discharged through nuclear
pores (nucleus membrane holes) into the cytoplasm. The
nucleus experiences pyknosis, and the cell cytoplasm de-
creases followed by karyorrhexis (Studdert 2008).
This study aimed to develop robust detecting methods
of field case based on the amplification of the gD gene
with an excellent quality of molecular sequence data. The
research process is described in Figure 6. The nested PCR
(nPCR) method used a pair of primers (Rola et al. 2005).
Nested PCR can overcome a low quality of DNA (Aswad
and Katzourakis 2014). This method also offers much
more sensitive detection than viral isolation (Babiuk et al.
1996), where nested PCR is able to detect 100–1000 fold
more sensitively than viral isolation (Masri et al. 1996).
An amplified gene of 325 bp was observed, with no false
positive result. The fragment was ligated into the pGEM-
FIGURE 6 The whole genome of BHV-1. The genome is classified
into two parts of Unique Long (UL) segment of the length of about
106 kb andUnique Short (US) segment of the length of about 10 kb.
The US is enclosed by the internal repeat (IR) and terminal repeat
(TR) short that are reverted to each other. The UL also enclosed
by the IR and terminal repeat long (TRL) and often observed in a
single orientation. The glycoprotein D (gD) gene was in the US re-
gion. The amplification of 325bpof gDwasmadeusing twopairs of
primer (nested PCR). The amplified gene was inserted into pGEM-
T and cloned into a competent cell. The plasmid was cut using the
ScaI restriction enzyme before being subjected to sequencing.
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TABLE 4 The results of restriction enzyme analysis using in silico AluI and TaqI.
Group Sequence gD restriction enzyme
AluI TaqI
Subtype-1.1 AJ004801 2 (nt 126, 163) 4 (nt 21, 198, 228, 290)
KU198480 2 (nt 126, 163) 4 (nt 21, 198, 228, 290)
JX8982201 2 (nt 126, 163) 4 (nt 21, 198, 228, 290)
KY2159441 2 (nt 126, 163) 4 (nt 21, 198, 228, 290)
Subtype-1.2 KM258882 3 (nt 126, 163, 295) 5 (nt 21, 198, 228, 290, 297)
KM258883 3 (nt 126, 163, 295) 5 (nt 21, 198, 228, 290, 297)
Samples W/5 3 (nt 126, 163, 295) 5 (nt 21, 198, 228, 290, 297)
T and cloned to competent E. coli C3040. The molecular
cloning of the specific plasmid could control the enhance-
ment quality of the DNA.
We used the gD gene sequence with a primer design
by Wiedmann et al. (1993). Subsequently, the cloning re-
sult was cut using the ScaI restriction enzyme. The ScaI
restriction enzyme enables natural DNA linearization by
cutting the plasmid DNA on a point AGT-ACT. Based on
our experiences during the study, the plasmid that has been
linearized using the ScaI enzyme is more accessible to se-
quence and gives excellent results, possibly due to the high
GC content in the genome sequence of BHV-1. The GC
content caused stable bonding within its nucleotide. The
GC content of the sequence alignment was 64%, similar to
suid herpesvirus and human herpesvirus (70%) (Dummer
et al. 2014). Davison and Clements (2010) stated that the
genome of BHV-1 was 125–240 kbp and had a nucleotide
composition of GC that varied from 32 to 74%.
The sequence had a high similarity with BHV-1.2
strain SM023 (ref. no. KM258882.1) and BHV-1.2 strain
SP1777 (KM258883.1). Themutation along this sequence
occurred at four points of mutation, as shown in Table 3.
The transition changed the purine nucleotide (A to G) and
pyrimidine nucleotide (T to C). The transition more fre-
quently takes place along the sequence as compared to the
transversion, but the transversion is more capable in de-
termining the difference in the genetic distance compared
with the transition. The result of synonymous and nonsyn-
onymous ratio indicated that this sequence has a negative
selection, meaning that the sequence has experienced pu-
rification selection (Traesel et al. 2014).
This study also used the restriction enzyme prediction
AluI and TaqI to proof the similarity of the sample and
reference genes. Restriction enzyme analysis, particularly
AluI and TaqI, was used to confirm the specificity of the se-
quence (Rola et al. 2005). Previously, restriction enzyme
analysis site was used to differentiate the type and subtype
of BHV-1 (Metzler et al. 1985; Spilki et al. 2004). Previ-
ous researchers also used this method to define the sub-
type of BHV-1 in Java, Indonesia (Saepulloh and Adjid
2010). It resulted in two fragments: 231 and 133 bp by
TaqI, and 322 and 124 bp by AluI. They classified samples
from Java in subtype 1.1. This study used a recent example
from Lampung, and revealed a different result. Previous
research by Noor et al. (2019) resulted in a mixed allele
using the AluI and TaqI restriction enzymes. The restric-
tion endonuclease analysis (REA) methods could have in-
stability because the genomic changes of the virus inside
the host body, resulting from various tissue sources. How-
ever, the BHV-1 genome has four isomeric forms, gen-
erated from a flip-flop direction during DNA replication
(Schynts et al. 2003a). It showed three points of inter-
section with AluI and five intersection points with TaqI.
This study also revealed that the similarity between the
sample and reference gene was 98.7–100%; the restric-
tion enzyme mapping of the samples was similar to that of
the BHV-1.2 reference gene. However, antigenically, the
BHV-1.1 subtype had a high similarity with subtype 1.2
(98.7–99.8%), as stated by Esteves et al. (2008). The ge-
netic distance of a sequence to other sequences can bemea-
sured using evolutionary distances reconstructed by vari-
ability within the nucleotide sequence (Turin et al. 1999).
The phylogenetic tree clearly showed that the sample was
grouped in the same branch as subtype 1.2.
5. Conclusions
Based on molecular analysis using SNP and in silico REA
using AluI and TaqI, the BHV-1 of an Indonesian isolate
found in a recent case was very similar to subtype 1.2.
Acknowledgments
The authors would like to extend their gratitude to
the Director of the Advanced Research Support Centre
(ADRES), Ehime University, Japan, the Director of An-
imal Health, the Ministry of Agriculture of the Republic
of Indonesia for promoting data of the research; the Head
of Veterinary Disease Investigation Lampung for the sam-
ples; and the Head of PUSVETMA for facilitating the cell
culture. This study was supported by the Japan Student
Service Organization.
Authors’ contributions
DNH established the objectives of the study, designed,
planned, EAS supported the molecular analysis, TU,
40
Hidayati et al. Indonesian Journal of Biotechnology 24(1), 2019, 34–42
MHW, AK, and WA and supervised the experiments and
corrected the manuscript. All of the authors read and ap-
proved the final manuscript.
Competing interests
The authors state that they have no competing interest.
References
Ackermann M, Engels M. 2006. Pro and contra IBR-
eradication. Vet Microbiol. 113(3-4):293–302. doi:
10.1016/j.vetmic.2005.11.043.
Aswad A, Katzourakis A. 2014. The first endogenous her-
pesvirus, identified in the tarsier genome, and novel se-
quences from primate rhadinoviruses and lymphocryp-
toviruses. PLoS Genetics. 10(6):e1004332. doi:10.
1371/journal.pgen.1004332.
Babiuk L, van Drunen Littel-van den Hurk S, Tikoo S.
1996. Immunology of bovine herpesvirus 1 infec-
tion. Vet Microbiol. 53(1–2):31–42. doi:10.1016/
S0378-1135(96)01232-1.
Babiuk LA. 2002. Vaccination: A management tool in
veterinary medicine. Vet J. 164(3):188–201. doi:10.
1053/tvjl.2001.0663.
Bashir S, Singh R, Sharma B, Yadav SK. 2011. Develop-
ment of a sandwich ELISA for the detection of bovine
herpesvirus type 1. Asian Pac J Trop Med. 4(5):363–
366. doi:10.1016/s1995-7645(11)60104-1.
Collins JK, Ayers VK, Whetstone CA, van Drunen Littel-
van den Hurk S. 1993. Antigenic differences be-
tween the major glycoproteins of bovine herpesvirus
type 1.1 and bovine encephalitis herpesvirus type
1.3. J Gen Virol. 74(8):1509–1517. doi:10.1099/
0022-1317-74-8-1509.
Cowley DJB, Graham DA, Guelbenzu M, Doherty ML,
More SJ. 2014. Aspects of bovine herpesvirus 1
and bovine viral diarrhoea virus herd-level seropreva-
lence and vaccination in dairy and beef herds in
Northern Ireland. Ir Vet J. 67(1):18. doi:10.1186/
2046-0481-67-18.
Davison AJ, Clements JB. 2010. Herpesviruses: general
properties. In: Mahy BW, ter Meulen V, Borriello SP,
Murray PR, Funke G, Kaufmann SH, Steward MW,
Merz WG, Hay RJ, Cox F, Wakelin D, Gillespie SH,
Despommier DD, Borriello SP, Murray PR, Funke
G, editors. Topley & Wilson’s microbiology and mi-
crobial infections. Chichester: John Wiley & Sons.
doi:10.1002/9780470688618.taw0231.
Dummer LA, Leite FPL, van Drunen Littel-van den Hurk
S. 2014. Bovine herpesvirus glycoprotein D: a re-
view of its structural characteristics and applications
in vaccinology. Vet Res. 45(111):1–12. doi:10.1186/
s13567-014-0111-x.
Esteves P, Dellagostin O, Pinto L, Silva A, Spilki F,
Ciacci-Zanella J, Hübner S, Puentes R, Maisonnave
J, Franco A, Rijsewijk F, Batista H, Teixeira T, Dezen
D, Oliveira A, David C, Arns C, Roehe P. 2008. Phylo-
genetic comparison of the carboxy-terminal region of
glycoprotein C (gC) of bovine herpesviruses (BoHV)
1.1, 1.2 and 5 from South America (SA). Virus Res.
131(1):16–22. doi:10.1016/j.virusres.2007.08.004.
Hidayati DN, Untari T, Wibowo MH, Akiyama K, As-
mara W. 2018. Cloning and sequencing gB, gD, and
gM genes to perform the genetic variability of bovine
herpesvirus-1 from Indonesia. VetWorld. 11(9):1255–
1261. doi:10.14202/vetworld.2018.1255-1261.
Jones C, Chowdhury S. 2007. A review of the bi-
ology of bovine herpesvirus type 1 (BHV-1), its
role as a cofactor in the bovine respiratory dis-
ease complex and development of improved vaccines.
Anim Health Res Rev. 8(2):187–205. doi:10.1017/
s146625230700134x.
Kaashoek MJ, Van Oirschot JT. 1996. Early immunity
induced by a live gE-negative bovine herpesvirus 1
marker vaccine. Vet Microbiol. 53(1-2):191–197. doi:
10.1016/s0378-1135(96)01247-3.
Kit S, Qavi H, Gaines JD, Billingsley P, McConnell S.
1985. Thymidine kinase-negative bovine herpesvirus
type 1 mutant is stable and highly attenuated in calves.
Arch Virol. 86(1-2):63–83. doi:10.1007/bf01314114.
Masri SA, Olson W, Nguyen PT, Prins S, Deregt D. 1996.
Rapid detection of bovine herpesvirus 1 in the semen
of infected bulls by a nested polymerase chain reaction
assay. Can J Vet Res. 60(2):100–107.
Metzler AE, Matile H, Gassmann U, Engels M, Wyler R.
1985. European isolates of bovine herpesvirus 1: A
comparison of restriction endonuclease sites, polypep-
tides, and reactivity with monoclonal antibodies. Arch
Virol. 85(1-2):57–69. doi:10.1007/bf01317006.
Muylkens B, Thiry J, Kirten P, Schynts F, Thiry E. 2007.
Bovine herpesvirus 1 infection and infectious bovine
rhinotracheitis. Vet Res. 38(2):181–209. doi:10.1051/
vetres:2006059.
Nandi S, Kumar M, Manohar M, Chauhan RS.
2009. Bovine herpes virus infections in cat-
tle. Anim Health Res Rev. 10(1):85–98.
doi:10.1017/s1466252309990028.
Noor HD, Tri U, Haryadi WM, Widya A, Koichi A. 2019.
Dna sequence variability analysis of the gD and the
UL36 genes of bovine herpesvirus-1 isolated from
field cases in Indonesia. J Appl Anim Res. 47(1):206–
211. doi:10.1080/09712119.2019.1600521.
Parreño V, López MV, Rodriguez D, Vena MM, Izuel
M, Filippi J, Romera A, Faverin C, Bellinzoni R,
Fernandez F, Marangunich L. 2010. Development
and statistical validation of a guinea pig model for
vaccine potency testing against infectious bovine
rhinothracheitis (IBR) virus. Vaccine. 28(13):2539–
2549. doi:10.1016/j.vaccine.2010.01.035.
Payment P, Assaf R, Trudel M, Marois P. 1979. Enzyme-
linked immunosorbent assay for serology of infectious
bovine rhinotracheitis virus infections. J Clin Micro-
biol. 10(5):633–636.
Pidone CL, Galosi CM, Echeverria MG, Nosetto EO,
Etcheverrigaray ME. 1999. Restriction endonucle-
ase analysis of BHV-1 and BHV-5 strains isolated in
41
Hidayati et al. Indonesian Journal of Biotechnology 24(1), 2019, 34–42
Argentina. J Vet Med Ser B. 46(7):453–456. doi:
10.1046/j.1439-0450.1999.00257.x.
Raaperi K, Orro T, Viltrop A. 2015. Effect of vacci-
nation against bovine herpesvirus 1 with inactivated
gE-negative marker vaccines on the health of dairy
cattle herds. Prev Vet Med. 118(4):467–476. doi:
10.1016/j.prevetmed.2015.01.014.
Rola J, Larska M, Polak MP. 2005. Detection of bovine
herpesvirus 1 from an outbreak of infectious bovine
rhinotracheitis. Bull Vet Inst Pulawy. 49:267–271.
Saepulloh M, Adjid RMA. 2010. Isolasi dan identifikasi
bovine herpesvirus-1 pada sapi perah dan potong
di Indonesia [Isolation and identification of bovine
herpesvirus-1 in Indonesian dairy and beef cattle]. Ju-
rnal Ilmu Ternak dan Veteriner. 19(2):376–387.
Saepulloh M, Wibawan IWT, Sajuthi D, Setiyaningsih
S. 2009. Karakterisasi molekuler bovine herpesvirus
type 1 isolat Indonesia [Molecular characterization of
Indonesian isolate of bovine herpesvirus type 1]. Jur-
nal Ilmu Ternak dan Veteriner. 14(1):66–74.
Sambrook J, Fritsch EF, Maniatis T. 1989. Molecular
cloning: a laboratory manual. 2nd edition. New York:
Cold Spring Harbor Laboratory Press.
Schynts F, McVoy MA, Meurens F, Detry B, Epstein AL,
Thiry E. 2003a. The structures of bovine herpesvirus 1
virion and concatemeric DNA: implications for cleav-
age and packaging of herpesvirus genomes. Virol-
ogy. 314(1):326–335. doi:10.1016/s0042-6822(03)
00437-9.
Schynts F, Meurens F, Detry B, Vanderplasschen A, Thiry
E. 2003b. Rise and survival of bovine herpesvirus 1
recombinants after primary infection and reactivation
from latency. J Virol. 77(23):12535–12542. doi:10.
1128/jvi.77.23.12535-12542.2003.
Smith GA, Young PL, Rodwell BJ, Kelly MA, Storie GJ,
Farrah CA, Mattick JS. 1994. Development and trial
of a bovine herpesvirus 1-thymidine kinase deletion
virus as a vaccine. Aust Vet J. 71(3):65–70. doi:10.
1111/j.1751-0813.1994.tb03329.x.
Spilki FR, Esteves PA, de Lima M, Franco AC, Chimi-
nazzo C, Flores EF, Weiblen R, Driemeier D, Roehe
PM. 2004. Comparative pathogenicity of bovine her-
pesvirus 1 (BHV-1) subtypes 1 (BHV-1.1) and 2a
(BHV-1.2a). Pesqui Vet Bras. 24(1):43–49. doi:10.
1590/s0100-736x2004000100010.
Strube W, Auer S, Block W, Heinen E, Kretzdorn D,
Rodenbach C, Schmeer N. 1996. A gE deleted
infectious bovine rhinotracheitis marker vaccine for
use in improved bovine herpesvirus 1 control pro-
grams. Vet Microbiol. 53(1-2):181–189. doi:10.1016/
s0378-1135(96)01246-1.
Studdert MJ. 2008. Bovine herpesviruses. In: Mahy B,
van Regenmortel M, editors. Desk encylopedia of an-
imal and bacterial virology. Oxford: Academic Press.
p. 65–71.
Sudarisman. 2006. Tingkat efikasi berbagai vaksin IBR in-
aktif yang dibuat menggunakan virus isolat lokal pada
sapi perah di Kabupaten Bandung yang diuji dengan
uji serum netralisasi. Jurnal Veteriner. 7(4):139–147.
Traesel CK, e Silva MS, Weiss M, Spilki FR, Weiblen
R, Flores EF. 2014. Genetic diversity of 3’ re-
gion of glycoprotein D gene of bovine herpesvirus 1
and 5. Virus Genes. 48(3):438–447. doi:10.1007/
s11262-014-1040-5.
Turin L, Russo S, Poli G. 1999. BHV-1: New molecu-
lar approaches to control a common and widespread
infection. Mol Med. 5(5):261–284. doi:10.1007/
bf03402063.
van Donkersgoed J, Guenther C, Evans BN, Potter AA,
Harland RJ. 1995. Effects of various vaccination pro-
tocols on passive and active immunity to Pasteurella
haemolytica and Haemophilus somnus in beef calves.
Can Vet J. 36(7):424–429.
van Engelenburg FAC, Kaashoek MJ, Rijsewijk FAM,
van den Burg L, Moerman A, Gielkens ALJ, van
Oirschot JT. 1994. A glycoprotein E deletion
mutant of bovine herpesvirus 1 is avirulent in
calves. J Gen Virol. 75(9):2311–2318. doi:10.1099/
0022-1317-75-9-2311.
Varela A, Holz C, Cibulski S, Teixeira T, Antunes D,
Franco A, Roehe L, Oliveira M, Campos F, Dezen D,
Cenci A, Brito W, Roehe P. 2010. Neutralizing an-
tibodies to bovine herpesvirus types 1 (BoHV-1) and
5 (BoHV-5) and its subtypes. Vet Microbiol. 142(3-
4):254–260. doi:10.1016/j.vetmic.2009.10.016.
Vlček Č, Beneš V, Lu Z, Kutish GF, Pačes V, Rock D,
Letchworth GJ, Schwyzer M. 1995. Nucleotide se-
quence analysis of a 30-kb region of the bovine her-
pesvirus 1 genome which exhibits a colinear gene ar-
rangement with the UL21 to UL4 genes of herpes sim-
plex virus. Virology. 210(1):100–108. doi:10.1006/
viro.1995.1321.
Weiblen R, Kreutz LC, Canabarro TF, Schuch LF, Re-
belatto MC. 1992. Isolation of bovine herpesvirus
1 from preputial swabs and semen of bulls with bal-
anoposthitis. J Vet Diagn Invest. 4(3):341–343. doi:
10.1177/104063879200400321.
Wiedmann M, Brandon R, Wagner P, Dubovi EJ, Batt CA.
1993. Detection of bovine herpesvirus-1 in bovine
semen by a nested PCR assay. J Virol Methods.
44(1):129–139. doi:10.1016/0166-0934(93)90015-j.
Zhu L, Thompson J, Ma F, Eudy J, Jones C. 2017. Ef-
fects of the synthetic corticosteroid dexamethasone on
bovine herpesvirus-1 productive infection. Virology.
505:71–79. doi:10.1016/j.virol.2017.02.012.
42
